Cargando…
Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature
OBJECTIVE: Clinicians predominantly use clinical features to differentiate type 1 from type 2 diabetes yet there are no evidence-based clinical criteria to aid classification of patients. Misclassification of diabetes is widespread (7–15% of cases), resulting in patients receiving inappropriate trea...
Autores principales: | Shields, Beverley M, Peters, Jaime L, Cooper, Chris, Lowe, Jenny, Knight, Bridget A, Powell, Roy J, Jones, Angus, Hyde, Christopher J, Hattersley, Andrew T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636628/ https://www.ncbi.nlm.nih.gov/pubmed/26525723 http://dx.doi.org/10.1136/bmjopen-2015-009088 |
Ejemplares similares
-
Identifying clinical criteria to predict Type 1 diabetes, as defined by absolute insulin deficiency: a systematic review protocol
por: Shields, Beverley M, et al.
Publicado: (2012) -
Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study
por: Oram, Richard A, et al.
Publicado: (2013) -
Strategies to identify individuals with monogenic diabetes: results of an economic evaluation
por: Peters, Jaime L, et al.
Publicado: (2020) -
Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years
por: Lynam, Anita, et al.
Publicado: (2019) -
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol
por: Angwin, Catherine, et al.
Publicado: (2020)